![](/img/cover-not-exists.png)
Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa : Implications for patients with cystic fibrosis(CF)
Millar, B. Cherie, Malnarcic, Camila M., McCaughan, John, Moore, John E.Language:
english
Journal:
The Clinical Respiratory Journal
DOI:
10.1111/crj.13100
Date:
October, 2019
File:
PDF, 4.32 MB
english, 2019